Serum levels of 3-Epi-25-OH-D3 during Hypervitaminosis D in Clinical Practice
- 1 December 2012
- journal article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 97 (12) , E2266-E2270
Abstract
Intoxication from vitamin D supplements has been rarely reported, but nowadays, it occurs more frequently. The presence of the C-3 epimer of 25-hydroxyvitamin D(3) (3-epi-25-OH-D(3)) is highly prevalent in adults, although there is little information regarding its in vivo relevance, if any, especially under pathological conditions. Our aim was to assess the presence of the 3-epi-25-OH-D(3) in serum samples displaying 25-OH-D(3) concentrations indicative of hypervitaminosis D. A total of 58 samples displaying a wide range of concentrations of 25-OH-D(3) (>64-439 ng/ml) by ultrafast liquid chromatography were consecutively recruited and reassessed for the presence of 3-epi-25-OH-D(3) using a second chromatographic system. Data from additional biochemical tests performed as part of the patient evaluation were also recorded. Mean relative contribution of 3-epi-25-OH-D(3) was less than 4%, and concentrations ranged from 2-28.6 ng/ml. Serum levels of the C3 epimer, but not the relative contribution, correlate with serum 25-OH-D(3). Overall, in subjects with 25-OH-D(3) concentrations indicative of hypervitaminosis D, the presence of the C-3 epimer and its levels were apparently unrelated to age, serum markers of renal and liver function, acute-phase reactants, and the presence of hypercalcemia. 3-Epi-25-OH-D(3) did not correlate with PTH, but subjects displaying PTH suppression (<14 pg/ml) showed higher concentrations of 3-epi-25-OH-D(3). The relative contribution of 3-epi-25-D(3) was not significantly altered during hypervitaminosis D, although the absolute levels reached in serum may be biologically relevant. From a clinical viewpoint, although the small size of the group may affect the lack of relationships, the presence of 3-epi-25-OH-D(3) was apparently unrelated to serum markers of renal and liver function, acute-phase reactants, PTH, and the presence of hypercalcemia.Keywords
This publication has 19 references indexed in Scilit:
- 3-epi-25 hydroxyvitamin D concentrations are not correlated with age in a cohort of infants and adultsClinica Chimica Acta, 2012
- Vitamin D Intoxication with Severe Hypercalcemia due to Manufacturing and Labeling Errors of Two Dietary Supplements Made in the United StatesThe Journal of Clinical Endocrinology & Metabolism, 2011
- Vitamin D and public health: an overview of recent research on common diseases and mortality in adulthoodPublic Health Nutrition, 2011
- Vitamin D Toxicity due to a Commonly Available “Over the Counter” Remedy from the Dominican RepublicThe Journal of Clinical Endocrinology & Metabolism, 2011
- 1,25-Dihydroxyvitamin D is not responsible for toxicity caused by vitamin D or 25-hydroxyvitamin DArchives of Biochemistry and Biophysics, 2011
- Full-scan mass spectral evidence for 3-epi-25-hydroxyvitamin D3 in serum of infants and adultsClinical Chemistry and Laboratory Medicine (CCLM), 2010
- Life-threatening complications of vitamin D intoxication due to over-the-counter supplementsClinical Toxicology, 2010
- Hypercalcemia due to Hypervitaminosis D: Report of Seven PatientsJournal of Tropical Pediatrics, 2009
- Pharmacokinetics of vitamin D toxicityThe American Journal of Clinical Nutrition, 2008
- C-3 Epimers Can Account for a Significant Proportion of Total Circulating 25-Hydroxyvitamin D in Infants, Complicating Accurate Measurement and Interpretation of Vitamin D StatusThe Journal of Clinical Endocrinology & Metabolism, 2006